From: Engineering probiotics as living diagnostics and therapeutics for improving human health
Condition | Probiotic used | Animal model | Administration | Refs. |
---|---|---|---|---|
Diabetes | L. lactis | Mice | Oral | |
 | L. lactis | Rats | Oral | [39] |
 | L. gasseri | Rats | Oral | [22] |
Phenylketonuria | E. coli Nissle 1917 | Mice/monkeys | Oral | [28] |
Hyperammonemia | L. helveticus | Rats | Oral | [47] |
 | Gut microbiota of murine | Mice | ASF | [48] |
 | E. coli Nissle 1917 | Mice | Oral | [29] |
P. aeruginosa infection | E. coli | In vitro | None | |
 | E. coli Nissle 1917 | Mice | Oral | [57] |
EHEC/S. aureus/S. epidermidis infection | E. coli Nissle 1917 | In vitro | None | [62] |
Salmonella infection | E. coli Nissle 1917 | Mice | Oral | [68] |
 | E. coli Nissle 1917 | In vitro | None | [61] |
 | E. coli Nissle 1917 | Turkey | Oral | [71] |
V. cholerae infection | E. coli Nissle 1917 | Mice | Oral | |
 | L. lactis | Mice | Oral | [77] |
 | V. cholerae | Rabbit | Oral | [78] |
 | L. lactis | Mice | Oral | [77] |
Liver metastasis | E. coli Nissle 1917 | Mice | Oral | [87] |
Gut inflammation | E. coli | In vitro | None | |
 | E. coli Nissle 1917 | Mice | Oral | [98] |